Preview

Russian Journal of Cardiology

Advanced search

Real-world data on managing patients with coronary artery disease and multifocal atherosclerosis. Results of the 12-month international clinical registry of patients with identified multifocal atherosclerosis in the Russian Federation and Eurasian countries (KAMMA)

  G. P. Arutyunov,   E. I. Tarlovskaya,   A. G. Arutyunov,   T. I. Batluk,   N. A. Koziolova,   A. I. Chesnikova,   A. Y. Vaskin,   D. S. Tokmin,   I. G. Bakulin,   O. L. Barbarash,   N. Y. Grigoryeva,   I. V. Gubareva,   N. V. Izmozherova,   U. R. Kamilova,   S. G. Kechedzhieva,   Z. F. Kim,   N. A. Koriagina,   S. V. Mironova,   N. P. Mitkovskaya,   S. V. Nemirova,   L. M. Nurieva,   M. M. Petrova,   E. A. Polyanskaya,   A. P. Rebrov,   A. V. Svarovskaya,   E. A. Smirnova,   A. B. Sugraliev,   Y. B. Khovaeva,   G. V. Shavkuta,   I. I. Shaposhnik, G. T. Aimakhanova,   M. Y. Alieva,   A. B. Almukhanova,   A. V. Aparkina,   D. A. Akhmentaeva,   R. A. Bashkinov,   N. M. Bekisheva,   L. N. Belousova,   E. I. Blokhina,   V. O. Bochkareva,   M. V. Buianova,   F. Y. Valikulova,   A. D. Vende,   A. S. Galyavich,   V. V. Genkel,   E. V. Gorbunova,   E. D. Gordeychuk,   E. A. Grigorenko,   E. V. Grigoryeva,   G. M. Dabylova,   I. L. Davydkin,   D. S. Evdokimov,   A. N. Ermilova,   S. B. Zhangelova,   N. V. Zhdankina,   E. I. Zheleznyak,   N. S. Ilyanok,   D. A. Kapsultanova,   N. A. Karoli,   E. A. Kartashova,   A. S. Kuznetsova,   A. T. Kumaritova,   N. A. Magdeeva,   S. A. Makarov,   O. A. Mamadaliev,   E. S. Melnikov,   N. J. Musrepov,   R. Ya. Namatova,   M. V. Novikova,   I. A. Obukhova, E. V. Ponomarenko,   A. O. Rubanenko,   O. A. Rubanenko,   V. A. Safronenko,   E. I. Suchkova,   A. I. Sycheva,   D. R. Tagaeva,   M. A. Trubnikova,   T. P. Trunina,   S. A. Tynalieva,   A. G. Frolov,   V. V. Khatlamadzhiyan,   Y. I. Khokhlova,   A. I. Chernyavina,   O. Y. Chizhova,   M. A. Shambatov,   T. V. Shnyukova,   Y. V. Shchukin

https://doi.org/10.15829/1560-4071-2025-6152

EDN: MBFXKR

Abstract

Aim. To study real-world data on managing patients with coronary artery disease (CAD) and multifocal atherosclerosis (MFA) for 12 months by outpatient cardiologists.
Material and methods. KAMMA is a real-world registry organized by the Eurasian Association of Therapists. The main branch included men and women over 18 years of age with confirmed atherosclerosis in two or more arterial systems and one or more risk factors for atherosclerosis. The start date for patient recruitment was February 1, 2022 and the end date was November 27, 2022. The design included 3 following visits: 1 — baseline, 2 — after 6 months, 3 — after 12 months. Twentyeight research centers were located in 7 federal districts of the Russian Federation, as well as in the Republics of Kazakhstan, Uzbekistan and Belarus.
Results. A patient population (n=2905) was formed, all of whom had verified CAD. The mean age was 66,0 [59,0; 72,0] years (men — 60,3%). Low-density lipoprotein cholesterol decreased by 20,4% over 12 months, while non-high-density lipoprotein cholesterol — by 12,7%. Over 12 months, lipid-lowering therapy did not undergo significant changes. Statin monotherapy was maintained in 83%, of which only 53,7% of patients received high-dose therapy. Combined statin+ezetimibe therapy was used in 12,4%, while statin+ezetimibe+PCSK9 inhibitor — in 4,6%. During the 1-year follow-up, antithrombotic therapy was not enhanced. Low prescription rate of combination therapy with antiplatelet agents (15,7%) and low-dose rivaroxaban and acetylsalicylic acid (7,9%) remained. By the follow-up end, a high incidence of major adverse cardiovascular events (8,8%) was registered in patients included in the KAMMA registry.
Conclusion. Despite the fact that patients with MFA have a very high cardiovascular risk, routine management of these patients is characterized by high clinical inertia. During the 1-year follow-up, lipid-lowering and antithrombotic therapy was not properly strengthened, due to which the target levels of key lipid profile parameters were not achieved and a high rate of major adverse cardiovascular events was observed in patients included in the registry.

About the Authors

G. P. Arutyunov
Association "Eurasian Association of Internal Medicine"; Pirogov Russian National Research Medical University
Russian Federation

Moscow


Competing Interests:

нет



E. I. Tarlovskaya
Association "Eurasian Association of Internal Medicine"; Privolzhsky Research Medical University
Russian Federation

Moscow

Nizhny Novgorod



A. G. Arutyunov
Association "Eurasian Association of Internal Medicine"; S. Avdalbekyan National Institute of Health
Russian Federation

Moscow

Yerevan


Competing Interests:

нет



T. I. Batluk
Association "Eurasian Association of Internal Medicine"
Russian Federation

Moscow


Competing Interests:

нет



N. A. Koziolova
E. A. Wagner Perm State Medical University
Russian Federation

Perm


Competing Interests:

нет



A. I. Chesnikova
Rostov State Medical University
Russian Federation

Rostov-on-Don 


Competing Interests:

нет



A. Y. Vaskin
Association "Eurasian Association of Internal Medicine"
Russian Federation

Moscow 


Competing Interests:

нет



D. S. Tokmin
"Alphastat" analytic agency
Russian Federation

Moscow


Competing Interests:

нет



I. G. Bakulin
I. I. Mechnicov North-Western State Medical University
Russian Federation

St. Petersburg


Competing Interests:

нет



O. L. Barbarash
Scientific Research Institute for Complex issues of cardiovascular disease
Russian Federation

Kemerovo


Competing Interests:

нет



N. Y. Grigoryeva
Lobachevsky National Research Nizhny Novgorod State University
Russian Federation

Nizhny Novgorod 


Competing Interests:

нет



I. V. Gubareva
Samara State Medical University
Russian Federation

Samara


Competing Interests:

нет



N. V. Izmozherova
Ural State Medical University
Russian Federation

Yekaterinburg


Competing Interests:

нет



U. R. Kamilova
Republican Specialized Scientific and Practical Medical Center of Therapy and Medical Rehabilitation
Uzbekistan

Tashkent


Competing Interests:

нет



S. G. Kechedzhieva
Stavropol State Medical University
Russian Federation

 Stavropol


Competing Interests:

нет



Z. F. Kim
Kazan State Medical University; Sadykov City Clinical Hospital № 7
Russian Federation

Kazan


Competing Interests:

нет



N. A. Koriagina
E. A. Wagner Perm State Medical University; LLC Women's Health Clinic
Russian Federation

Perm


Competing Interests:

нет



S. V. Mironova
Perm Regional Hospital for Veterans War
Russian Federation

Perm


Competing Interests:

нет



N. P. Mitkovskaya
Republican Scientific and Practical Center "Cardiology"
Belarus

Minsk 


Competing Interests:

нет



S. V. Nemirova
Privolzhsky Research Medical University
Russian Federation

Nizhny Novgorod


Competing Interests:

нет



L. M. Nurieva
Sadykov City Clinical Hospital № 7
Russian Federation

Kazan


Competing Interests:

нет



M. M. Petrova
V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation

Krasnoyarsk


Competing Interests:

нет



E. A. Polyanskaya
E. A. Wagner Perm State Medical University
Russian Federation

Perm


Competing Interests:

нет



A. P. Rebrov
V. I. Razumovskiy Saratov State Medical University; Regional Clinical Hospital
Russian Federation

Saratov


Competing Interests:

нет



A. V. Svarovskaya
Cardiology Research Institute; Tomsk National Research Medical Center
Russian Federation

Tomsk


Competing Interests:

нет



E. A. Smirnova
Pavlov Ryazan State Medical University
Russian Federation

Ryazan


Competing Interests:

нет



A. B. Sugraliev
Asfendiyarov Kazakh National Medical University
Kazakhstan

Almaty


Competing Interests:

нет



Y. B. Khovaeva
F. C. Gral City Clinical Hospital № 2
Russian Federation

Perm


Competing Interests:

нет



G. V. Shavkuta
Rostov State Medical University
Russian Federation

Rostov-on-Don


Competing Interests:

нет



I. I. Shaposhnik
South-Ural State Medical University
Russian Federation

Chelyabinsk 


Competing Interests:

нет



G. T. Aimakhanova
Asfendiyarov Kazakh National Medical University
Kazakhstan

Almaty


Competing Interests:

нет



M. Y. Alieva
Republican Specialized Scientific and Practical Medical Center of Therapy and Medical Rehabilitation
Uzbekistan

 Tashkent


Competing Interests:

нет



A. B. Almukhanova
Asfendiyarov Kazakh National Medical University
Kazakhstan

Almaty


Competing Interests:

нет



A. V. Aparkina
V. I. Razumovskiy Saratov State Medical University; Regional Clinical Hospital
Russian Federation

Saratov


Competing Interests:

нет



D. A. Akhmentaeva
Asfendiyarov Kazakh National Medical University
Kazakhstan

Almaty


Competing Interests:

нет



R. A. Bashkinov
Association "Eurasian Association of Internal Medicine"; I. I. Mechnicov North-Western State Medical University; Clinical Rheumatology Hospital № 25
Russian Federation

 Moscow 

 St. Petersburg


Competing Interests:

нет



N. M. Bekisheva
Asfendiyarov Kazakh National Medical University
Kazakhstan

Almaty


Competing Interests:

нет



L. N. Belousova
I. I. Mechnicov North-Western State Medical University
Russian Federation

St. Petersburg


Competing Interests:

нет



E. I. Blokhina
Lobachevsky National Research Nizhny Novgorod State University
Russian Federation

Nizhny Novgorod


Competing Interests:

нет



V. O. Bochkareva
V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation

Krasnoyarsk 


Competing Interests:

нет



M. V. Buianova
Lobachevsky National Research Nizhny Novgorod State University
Russian Federation

Nizhny Novgorod 


Competing Interests:

нет



F. Y. Valikulova
Privolzhsky Research Medical University; City Polyclinic № 31 of Sovetsky District
Russian Federation

Nizhny Novgorod


Competing Interests:

нет



A. D. Vende
Cardiology Research Institute; Tomsk National Research Medical Center
Russian Federation

Tomsk


Competing Interests:

нет



A. S. Galyavich
Kazan State Medical University
Russian Federation

 Kazan


Competing Interests:

нет



V. V. Genkel
South-Ural State Medical University
Russian Federation

Chelyabinsk


Competing Interests:

нет



E. V. Gorbunova
Scientific Research Institute for Complex issues of cardiovascular disease; L. S. Barbarash Kuzbass Clinical Cardiology Dispensary
Russian Federation

Kemerovo


Competing Interests:

нет



E. D. Gordeychuk
Association "Eurasian Association of Internal Medicine; Pirogov Russian National Research Medical University
Russian Federation

Moscow


Competing Interests:

нет



E. A. Grigorenko
Republican Scientific and Practical Center "Cardiology"
Belarus

Minsk 


Competing Interests:

нет



E. V. Grigoryeva
V. I. Razumovskiy Saratov State Medical University; Regional Clinical Hospital
Russian Federation

Saratov


Competing Interests:

нет



G. M. Dabylova
Asfendiyarov Kazakh National Medical University
Kazakhstan

Almaty


Competing Interests:

нет



I. L. Davydkin
Samara State Medical University
Russian Federation

Samara


Competing Interests:

нет



D. S. Evdokimov
I. I. Mechnicov North-Western State Medical University
Russian Federation

St. Petersburg


Competing Interests:

нет



A. N. Ermilova
Association "Eurasian Association of Internal Medicine; Fomin's clinic Michurinsky; Fomin's clinic Dolgorukovskaya
Russian Federation

Moscow


Competing Interests:

нет



S. B. Zhangelova
Asfendiyarov Kazakh National Medical University
Kazakhstan

Almaty


Competing Interests:

нет



N. V. Zhdankina
Lobachevsky National Research Nizhny Novgorod State University
Russian Federation

Nizhny Novgorod 


Competing Interests:

нет



E. I. Zheleznyak
Rostov State Medical University
Russian Federation

Rostov-on-Don


Competing Interests:

нет



N. S. Ilyanok
Pavlov Ryazan State Medical University
Russian Federation

Ryazan


Competing Interests:

нет



D. A. Kapsultanova
Asfendiyarov Kazakh National Medical University
Kazakhstan

Almaty


Competing Interests:

нет



N. A. Karoli
V. I. Razumovskiy Saratov State Medical University; Regional Clinical Hospital
Russian Federation

Saratov


Competing Interests:

нет



E. A. Kartashova
Rostov State Medical University
Russian Federation

Rostov-on-Don


Competing Interests:

нет



A. S. Kuznetsova
South-Ural State Medical University
Russian Federation

Chelyabinsk


Competing Interests:

нет



A. T. Kumaritova
I. I. Mechnicov North-Western State Medical University
Russian Federation

St. Petersburg


Competing Interests:

нет



N. A. Magdeeva
V. I. Razumovskiy Saratov State Medical University; Regional Clinical Hospital
Russian Federation

Saratov


Competing Interests:

нет



S. A. Makarov
Scientific Research Institute for Complex issues of cardiovascular disease
Russian Federation

 Kemerovo 


Competing Interests:

нет



O. A. Mamadaliev
Asfendiyarov Kazakh National Medical University
Kazakhstan

Almaty


Competing Interests:

нет



E. S. Melnikov
Association "Eurasian Association of Internal Medicine"; I. I. Mechnicov North-Western State Medical University; Clinical Rheumatology Hospital № 25
Russian Federation

Moscow 

St. Petersburg


Competing Interests:

нет



N. J. Musrepov
Asfendiyarov Kazakh National Medical University
Kazakhstan

Almaty


Competing Interests:

нет



R. Ya. Namatova
Asfendiyarov Kazakh National Medical University
Kazakhstan

Almaty


Competing Interests:

нет



M. V. Novikova
Stavropol Regional Cardiology Dispensary
Russian Federation

Stavropol 


Competing Interests:

нет



I. A. Obukhova
V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation

Krasnoyarsk


Competing Interests:

нет



E. V. Ponomarenko
LLC "Health Formula"
Russian Federation

Krasnodar 


Competing Interests:

нет



A. O. Rubanenko
Samara State Medical University
Russian Federation

Samara



O. A. Rubanenko
Samara State Medical University
Russian Federation

Samara


Competing Interests:

нет



V. A. Safronenko
Rostov State Medical University
Russian Federation

Rostov-on-Don



E. I. Suchkova
Pavlov Ryazan State Medical University
Russian Federation

Ryazan


Competing Interests:

нет



A. I. Sycheva
F. C. Gral City Clinical Hospital № 2

Perm


Competing Interests:

нет



D. R. Tagaeva
Republican Specialized Scientific and Practical Medical Center of Therapy and Medical Rehabilitation
Uzbekistan

 Tashkent


Competing Interests:

нет



M. A. Trubnikova
Association "Eurasian Association of Internal Medicine"; LLC "Dr. Fomin's clinic"
Russian Federation

Moscow 

Sochi


Competing Interests:

нет



T. P. Trunina
Pavlov Ryazan State Medical University; City Clinical Hospital № 11
Russian Federation

Ryazan


Competing Interests:

нет



S. A. Tynalieva
Asfendiyarov Kazakh National Medical University
Kazakhstan

Almaty


Competing Interests:

нет



A. G. Frolov
Lobachevsky National Research Nizhny Novgorod State University
Russian Federation

Nizhny Novgorod


Competing Interests:

нет



V. V. Khatlamadzhiyan
Rostov State Medical University
Russian Federation

Rostov-on-Don


Competing Interests:

нет



Y. I. Khokhlova
I. I. Mechnicov North-Western State Medical University
Russian Federation

St. Petersburg


Competing Interests:

нет



A. I. Chernyavina
Perm Regional Hospital for Veterans War
Russian Federation

 Perm 


Competing Interests:

нет



O. Y. Chizhova
I. I. Mechnicov North-Western State Medical University
Russian Federation

St. Petersburg


Competing Interests:

нет



M. A. Shambatov
Ural State Medical University
Russian Federation

Yekaterinburg 


Competing Interests:

нет



T. V. Shnyukova
Rostov State Medical University
Russian Federation

Rostov-on-Don


Competing Interests:

нет



Y. V. Shchukin
Samara State Medical University
Russian Federation

Samara



References

1. Mazzolai L, Teixido-Tura G, Lanzi S, et al. ESC Scientific Document Group. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases: Developed by the task force on the management of peripheral arterial and aortic diseases of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN), and the European Society of Vascular Medicine (ESVM), European Heart Journal, 2024:ehae179. doi: 10.1093/eurheartj/ehae179.

2. Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. Peculiarities of polyvascular disease and the diagnostic significance of the ankle-brachial index in patients with coronary artery disease: results from the real-world registry KAMMA (Clinical registry on patient population with polyvascular disease in the Russian Federation and Eurasian countries). Russian Journal of Cardiology. 2024;29(4):5837. (In Russ.) doi: 10.15829/1560-4071-2024-5837.

3. Costa C, Riquito B, Perdigão S, et al. Undercover Peripheral Arterial Disease. Cureus. 2024;16(1):e51590. doi:10.7759/cureus.51590.

4. Bonaca MP, Nault P, Giugliano RP, et al. Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk). Circulation. 2018;137(4):338-50. doi:10.1161/CIRCULATIONAHA.117.032235.

5. Anand SS, Aboyans V, Bosch J, et al.; XATOA Steering Committee. Identifying the highest risk vascular patients: Insights from the XATOA registry. Am Heart J. 2024;269:191-200. doi: 10.1016/j.ahj.2024.01.001.

6. Ray KK, Haq I, Bilitou A, et al.; SANTORINI Study Investigators. Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study. Lancet Reg Health Eur. 2023;29:100624. doi:10.1016/j.lanepe.2023.100624.

7. Hess CN Hess CN, Cannon CP, et al. Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease. J Am Coll Cardiol. 2021;77(24):3016-27. doi: 10.1016/j.jacc.2021.04.060.

8. Hess CN, Daffron A, Nehler MR, et al. Randomized Trial of a Vascular Care Team vs Education for Patients With Peripheral Artery Disease. J Am Coll Cardiol. 2024;83:2658-70.

9. Secemsky EA, Carroll BJ, Krawisz AK. The Ongoing Struggle to Optimize Lipid-Lowering Therapy in Patients With PAD: PADdling in Circles. J Am Coll Cardiol. 2021;77(24):3028-30. doi: 10.1016/j.jacc.2021.04.057.

10. Ranger GS, McKinley-Brown C, Rogerson E, Schimp-Manuel K. Aspirin Use, Compliance, and Knowledge of Anticancer Effect in the Community. Perm J. 2020;24:19. doi: 10.7812/TPP/19.116.

11. Ferreira PD Jr, Simoes JA Sr, Velho DC Sr. Adherence to Antihypertensive Therapy and Its Determinants: A Systematic Review. Cureus. 2024;16(5):e59532. doi: 10.7759/cureus.59532.

12. Russian Society of Cardiology (RSC). 2020 Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2020;25(11):4076. (In Russ.) doi: 10.15829/29/1560-4071-2020-4076.

13. Sheth MS, Yu B, Chu A, et al. Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice-Insights From the CANHEART Study. J Am Heart Assoc. 2022;11(24):e026553. doi:10.1161/JAHA.122.026553.

14. Lapébie FX, Aboyans V, Lacroix P, et al. Editor's Choice - External Applicability of the COMPASS and VOYAGER-PAD Trials on Patients with Symptomatic Lower Extremity Artery Disease in France: The COPART Registry. Eur J Vasc Endovasc Surg. 2021;62(3): 439-49. doi: 10.1016/j.ejvs.2021.05.028.

15. Eikelboom JW, Bhatt DL, Fox KAA, et al. Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease. J Am Coll Cardiol. 2021;78(1):14-23. doi: 10.1016/j.jacc.2021.04.083.

16. Gutierrez JA, Mulder H, Jones WS, et al. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial. JAMA Netw Open. 2018;1(7):e185239. doi: 10.1001/jamanetworkopen.2018.5239.


Supplementary files

  • During the 1-year follow-up, lipid-­lowering the­rapy of patients with coronary artery disease and multifocal atherosclerosis was not properly strengthened, due to which the target levels of key lipid profile parameters were not achieved in the vast majority of patients (low-density lipoprotein cholesterol in 78%, non-high-density lipoprotein cholesterol in 81%).
  • During the 1-year follow-up, antithrombotic the­rapy was not intensified' the low prescription rate of combination therapy with antiplatelet agents (15,7%) and low doses of rivaroxaban and acetylsalicylic acid (7,9%) remained.
  • By the end of the 12-month follow-up period, a high rate of major adverse cardiovascular events (8,8%) was registered in patients included in the KAMMA registry.

Review

For citations:


Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G., Batluk T.I., Koziolova N.A., Chesnikova A.I., Vaskin A.Y., Tokmin D.S., Bakulin I.G., Barbarash O.L., Grigoryeva N.Y., Gubareva I.V., Izmozherova N.V., Kamilova U.R., Kechedzhieva S.G., Kim Z.F., Koriagina N.A., Mironova S.V., Mitkovskaya N.P., Nemirova S.V., Nurieva L.M., Petrova M.M., Polyanskaya E.A., Rebrov A.P., Svarovskaya A.V., Smirnova E.A., Sugraliev A.B., Khovaeva Y.B., Shavkuta G.V., Shaposhnik I.I., Aimakhanova G.T., Alieva M.Y., Almukhanova A.B., Aparkina A.V., Akhmentaeva D.A., Bashkinov R.A., Bekisheva N.M., Belousova L.N., Blokhina E.I., Bochkareva V.O., Buianova M.V., Valikulova F.Y., Vende A.D., Galyavich A.S., Genkel V.V., Gorbunova E.V., Gordeychuk E.D., Grigorenko E.A., Grigoryeva E.V., Dabylova G.M., Davydkin I.L., Evdokimov D.S., Ermilova A.N., Zhangelova S.B., Zhdankina N.V., Zheleznyak E.I., Ilyanok N.S., Kapsultanova D.A., Karoli N.A., Kartashova E.A., Kuznetsova A.S., Kumaritova A.T., Magdeeva N.A., Makarov S.A., Mamadaliev O.A., Melnikov E.S., Musrepov N.J., Namatova R.Ya., Novikova M.V., Obukhova I.A., Ponomarenko E.V., Rubanenko A.O., Rubanenko O.A., Safronenko V.A., Suchkova E.I., Sycheva A.I., Tagaeva D.R., Trubnikova M.A., Trunina T.P., Tynalieva S.A., Frolov A.G., Khatlamadzhiyan V.V., Khokhlova Y.I., Chernyavina A.I., Chizhova O.Y., Shambatov M.A., Shnyukova T.V., Shchukin Y.V. Real-world data on managing patients with coronary artery disease and multifocal atherosclerosis. Results of the 12-month international clinical registry of patients with identified multifocal atherosclerosis in the Russian Federation and Eurasian countries (KAMMA). Russian Journal of Cardiology. 2025;30(3):6152. (In Russ.) https://doi.org/10.15829/1560-4071-2025-6152. EDN: MBFXKR

Views: 307


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)